Download PDF
Horm Metab Res 2018; 50(04): 271-279
DOI: 10.1055/s-0044-101355
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Maryam Akbari
1   Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
,
Vahidreza Ostadmohammadi
2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
,
Kamran B. Lankarani
3   Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
,
Reza Tabrizi
1   Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
,
Fariba Kolahdooz
4   Indigenous and Global Health Research, Department of Medicine, University of Alberta, Edmonton, Canada
,
Seyed Taghi Heydari
5   Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
,
Seyed Habibollah Kavari
6   Faculty member of Rehabilitation Management Department, School of Rehabilitation, University of Social Welfare and Rehabilitation Sciences (USWR),Tehran, Iran
,
Naghmeh Mirhosseini
7   Pure North S’Energy Foundation, Calgary, AB, Canada
,
Alireza Mafi
2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
,
Majid Dastorani
2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
,
Zatollah Asemi
2   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
› Author Affiliations
Further Information

Publication History

received 17 December 2017

accepted 10 January 2018

Publication Date:
23 February 2018 (online)

Also available at
    Permissions and Reprints

Abstract

The current systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to summarize the effect of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome (PCOS). Cochrane library, Embase, PubMed, and Web of Science database were searched to identify related randomized-controlled articles (RCTs) published up to November 2017. Two researchers assessed study eligibility, extracted data, and evaluated risk of bias of included RCTs, independently. To check heterogeneity Q-test and I2 statistics were used. Data were pooled by using the random-effect model and standardized mean difference (SMD) was considered as summary effect size. Seven RCTs were included into our meta-analysis. The findings showed that vitamin D supplementation in women with PCOS significantly decreased high-sensitivity C-reactive protein (hs-CRP) (SMD −1.03; 95% CI, −1.58, −0.49; p <0.001) and malondialdehyde (MDA) (SMD −1.64, 95% CI −2.26 to −1.02, p <0.001), and significantly increased total antioxidant capacity (TAC) levels (SMD 0.86, 95% CI 0.08 to 1.64, p=0.03). Vitamin D supplementation had no significant effect on nitric oxide (NO) (SMD 0.11, 95% CI −0.44 to 0.66, p=0.69) and total glutathione (GSH) levels (SMD 0.54, 95% CI −0.20 to 1.28, p=0.15). Overall, the current meta-analysis demonstrated that vitamin D supplementation to women with PCOS resulted in an improvement in hs-CRP, MDA and TAC, but did not affect NO and GSH levels.

Key words

vitamin D supplementation - inflammation - oxidative stress - polycystic ovary syndrome - meta-analysis
 

  • References

  • 1 Dewailly D. Diagnostic criteria for PCOS: Is there a need for a rethink?. Best Pract Res Clin Obstet Gynaecol 2016; 37: 5-11
    CrossrefPubMedGoogle Scholar
  • 2 Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749
    CrossrefPubMedGoogle Scholar
  • 3 Mohammadi S, Kayedpoor P, Karimzadeh-Bardei L, Nabiuni M. The effect of curcumin on tnf-alpha, il-6 and crp expression in a model of polycystic ovary syndrome as an inflammation state. J Reprod Infertil 2017; 18: 352-360
    PubMedGoogle Scholar
  • 4 Shorakae S, Teede H, de Courten B, Lambert G, Boyle J, Moran LJ. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Semin Reprod Med 2015; 33: 257-269
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Melo AS, Kliemchen J, Junior AA, Ferriani RA, Navarro PA. Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI. Reproduction 2016 pii: REP-16-0084 [Epub ahead of print]
    PubMed
  • 6 Hossein-Nezhad A, Mirzaei K, Keshavarz SA, Ansar H, Saboori S, Tootee A. Evidences of dual role of vitamin D through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects. Minerva Med 2013; 104: 295-307
    PubMedGoogle Scholar
  • 7 Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One 2015; 10: e0141770
    CrossrefPubMedGoogle Scholar
  • 8 Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, Claesson MH, Zocca MB. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol 2009; 157: 48-59
    CrossrefPubMedGoogle Scholar
  • 9 Chen N, Wan Z, Han SF, Li BY, Zhang ZL, Qin LQ. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 2014; 6: 2206-2216
    CrossrefPubMedGoogle Scholar
  • 10 Jamka M, Wozniewicz M, Walkowiak J, Bogdanski P, Jeszka J, Stelmach-Mardas M. The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis. Eur J Nutr. 2016; 55: 2163-2176
    CrossrefPubMedGoogle Scholar
  • 11 Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T, Nasri K, Asemi Z, Esmaillzadeh A. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol (Oxf) 2015; 83: 888-894
    CrossrefPubMedGoogle Scholar
  • 12 Maktabi M, Chamani M, Asemi Z. The Effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Horm Metab Res 2017; 49: 493-498
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Fatemi F, Mohammadzadeh A, Sadeghi MR, Akhondi MM, Mohammadmoradi S, Kamali K, Lackpour N, Jouhari S, Zafadoust S, Mokhtar S, Giahi L. Role of vitamin E and D3 supplementation in Intra-Cytoplasmic Sperm Injection outcomes of women with polycystic ovarian syndrome: A double blinded randomized placebo-controlled trial. Clin Nutr ESPEN 2017; 18: 23-30
    PubMedGoogle Scholar
  • 14 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    CrossrefPubMedGoogle Scholar
  • 15 Razavi M, Jamilian M, Karamali M, Bahmani F, Aghadavod E, Asemi Z. The Effects of vitamin D-K-Calcium co-supplementation on endocrine, inflammation, and oxidative stress biomarkers in vitamin d-deficient women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Horm Metab Res 2016; 48: 446-451
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Jamilian M, Foroozanfard F, Rahmani E, Talebi M, Bahmani F, Asemi Z. Effect of two different doses of vitamin d supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome. Nutrients 2017; 9 pii: E1280 DOI: 10.3390/nu9121280.
    CrossrefPubMedGoogle Scholar
  • 17 Maktabi M, Jamilian M, Asemi Z. Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 2017; DOI: 10.1007/s12011-017-1085-0. [Epub ahead of print]
    CrossrefPubMedGoogle Scholar
  • 18 Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A. The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Horm Metab Res 2017; 49: 174-179
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Rezvan N, Moini A, Janani L, Mohammad K, Saedisomeolia A, Nourbakhsh M, Gorgani-Firuzjaee S, Mazaherioun M, Hosseinzadeh-Attar MJ. Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Horm Metab Res 2017; 49: 115-121
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Abruzzese GA, Cerrrone GE, Gamez JM, Graffigna MN, Belli S, Lioy G, Mormandi E, Otero P, Levalle OA, Motta AB. Lipid accumulation product (LAP) and visceral adiposity index (vai) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 2017; 49: 23-29
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Calton EK, Keane KN, Soares MJ. The potential regulatory role of vitamin D in the bioenergetics of inflammation. Curr Opin Clin Nutr Metab Care 2015; 18: 367-373
    CrossrefPubMedGoogle Scholar
  • 22 Laird E, McNulty H, Ward M, Hoey L, McSorley E, Wallace JM, Carson E, Molloy AM, Healy M, Casey MC, Cunningham C, Strain JJ. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab 2014; 99: 1807-1815
    CrossrefPubMedGoogle Scholar
  • 23 Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?. Am J Med 2010; 123: 335-341
    CrossrefPubMedGoogle Scholar
  • 24 Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2013; 8: 33-40
    CrossrefPubMedGoogle Scholar
  • 25 Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012; 109: 226-230
    CrossrefPubMedGoogle Scholar
  • 26 Calton EK, Keane KN, Newsholme P, Zhao Y, Soares MJ. The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials. Eur J Clin Nutr 2017; 71: 931-943
    CrossrefPubMedGoogle Scholar
  • 27 Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, Klassen TP. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009; 339: b4012
    CrossrefPubMedGoogle Scholar
  • 28 Shen SH, Shen SY, Liou TH, Hsu MI, Chang YC, Cheng CY, Hsu CS, Tzeng CR. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 192: 66-71
    CrossrefPubMedGoogle Scholar
  • 29 Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006; 1092: 175-186
    CrossrefPubMedGoogle Scholar
  • 30 Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, van Leeuwen JP, Lubberts E. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010; 62: 132-142
    CrossrefPubMedGoogle Scholar
  • 31 Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, van der Ven AJ. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011; 164: 72-79
    CrossrefPubMedGoogle Scholar
  • 32 Al-Rasheed NM, Bassiouni YA, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mohamad RA. Vitamin D attenuates pro-inflammatory TNF-alpha cytokine expression by inhibiting NF-small ka, CyrillicB/p65 signaling in hypertrophied rat hearts. J Physiol Biochem 2015; 71: 289-299
    CrossrefPubMedGoogle Scholar
  • 33 Sepehrmanesh Z, Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi Z, Esmaillzadeh A. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J Nutr 2016; 146: 243-248
    CrossrefPubMedGoogle Scholar
  • 34 Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of oxidative stress during diabetes mellitus. J Biomark 2013; 378790
    PubMedGoogle Scholar
  • 35 Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 191: 15-22
    CrossrefPubMedGoogle Scholar
  • 36 Macut D, Bjekic-Macut J, Savic-Radojevic A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res 2013; 40: 51-63
    CrossrefPubMedGoogle Scholar
  • 37 Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun 2013; 437: 7-11
    CrossrefPubMedGoogle Scholar
  • 38 Martinesi M, Treves C, d'Albasio G, Bagnoli S, Bonanomi AG, Stio M. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients. Inflamm Bowel Dis 2008; 14: 597-604
    CrossrefPubMedGoogle Scholar
  • 39 Garcion E, Sindji L, Leblondel G, Brachet P, Darcy F. 1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem 1999; 73: 859-866
    PubMedGoogle Scholar
  • 40 Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993; 326: 285-288
    CrossrefPubMedGoogle Scholar
  • 41 Wu CC, Chang JH, Chen CC, Su SB, Yang LK, Ma WY, Zheng CM, Diang LK, Lu KC. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Tohoku J Exp Med 2011; 223: 153-159
    CrossrefPubMedGoogle Scholar
  • 42 Nasri K, Akrami S, Rahimi M, Taghizadeh M, Behfar M, Mazandaranian MR, Kheiry A, Memarzadeh MR, Asemi Z. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Endocr Res 2017; 1-10
    PubMedGoogle Scholar
  • 43 Rahimi-Ardabili H, Pourghassem Gargari B, Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest 2013; 36: 28-32
    PubMedGoogle Scholar